ENTA Enanta Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ENTA

Price (delayed)

$12.37

Market cap

$261.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.56

Enterprise value

$243.29M

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for the treatment of viral infections ...

Highlights
The debt has contracted by 3.9% from the previous quarter
Enanta Pharmaceuticals's quick ratio has decreased by 47% YoY and by 8% QoQ
The equity has decreased by 36% YoY and by 11% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.enanta.com
Peers: ENZN VRTX JNJ ABBV

Key stats

What are the main financial stats of ENTA
Market
Shares outstanding
21.16M
Market cap
$261.7M
Enterprise value
$243.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.36
Price to sales (P/S)
3.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.3
Earnings
Revenue
$73.62M
EBIT
-$127.42M
EBITDA
-$124.91M
Free cash flow
-$99.19M
Per share
EPS
-$6.56
Free cash flow per share
-$4.7
Book value per share
$9.11
Revenue per share
$3.49
TBVPS
$20.32
Balance sheet
Total assets
$428.5M
Total liabilities
$236.62M
Debt
$25.49M
Equity
$191.88M
Working capital
$327.9M
Liquidity
Debt to equity
0.13
Current ratio
6.25
Quick ratio
5.6
Net debt/EBITDA
0.15
Margins
EBITDA margin
-169.7%
Gross margin
100%
Net margin
-187.8%
Operating margin
-193%
Efficiency
Return on assets
-32.3%
Return on equity
-60.4%
Return on invested capital
-39.7%
Return on capital employed
-34.8%
Return on sales
-173.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENTA stock price

How has the Enanta Pharmaceuticals stock price performed over time
Intraday
-0.88%
1 week
-7.13%
1 month
-22.45%
1 year
-64.2%
YTD
31.46%
QTD
-29.15%

Financial performance

How have Enanta Pharmaceuticals's revenue and profit performed over time
Revenue
$73.62M
Gross profit
$73.62M
Operating income
-$142.08M
Net income
-$138.24M
Gross margin
100%
Net margin
-187.8%
The operating margin has contracted by 28% YoY and by 11% from the previous quarter
The net margin has contracted by 28% YoY and by 11% from the previous quarter
The company's operating income fell by 15% YoY and by 3.6% QoQ
ENTA's net income is down by 15% year-on-year and by 3.3% since the previous quarter

Growth

What is Enanta Pharmaceuticals's growth rate over time

Valuation

What is Enanta Pharmaceuticals stock price valuation
P/E
N/A
P/B
1.36
P/S
3.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.3
The EPS has declined by 13% year-on-year and by 2.8% since the previous quarter
ENTA's P/B is 48% below its 5-year quarterly average of 2.6 and 24% below its last 4 quarters average of 1.8
The equity has decreased by 36% YoY and by 11% from the previous quarter
The price to sales (P/S) is 60% lower than the 5-year quarterly average of 8.9 and 34% lower than the last 4 quarters average of 5.4
Enanta Pharmaceuticals's revenue has decreased by 10% YoY and by 7% from the previous quarter

Efficiency

How efficient is Enanta Pharmaceuticals business performance
Enanta Pharmaceuticals's return on equity has shrunk by 65% YoY and by 16% QoQ
The return on sales has declined by 17% year-on-year and by 9% since the previous quarter
ENTA's return on invested capital is down by 9% year-on-year but it is up by 2.2% since the previous quarter

Dividends

What is ENTA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENTA.

Financial health

How did Enanta Pharmaceuticals financials performed over time
The company's total assets is 81% higher than its total liabilities
Enanta Pharmaceuticals's current ratio has decreased by 49% YoY and by 7% from the previous quarter
Enanta Pharmaceuticals's quick ratio has decreased by 47% YoY and by 8% QoQ
The debt is 87% less than the equity
The company's debt to equity has surged by 63% YoY and by 8% QoQ
The equity has decreased by 36% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.